Biocompass

Biocompass (Beijing) Technology Co., Ltd. focuses on core scenarios in the fields of artificial intelligence and biopharmaceuticals, and is committed to achieving life engineering by building large AI virtual cell models. The company owns world-leading AI virtual cell algorithms, including the world's first pre-trained large cell model incorporating prior knowledge, which helps break through the randomness bottleneck of traditional bio-cell experiments and significantly improves the efficiency of drug discovery and biomanufacturing! It provides AI customized solutions for biopharmaceutical companies and research institutions in scenarios such as cell therapy, gene therapy, and recombinant protein production, helping enterprises address key challenges in the drug development process, reduce the failure rate of clinical trials, and increase the success rate of drug R&D!